Tuberculosis caused by primary infection of or reactivation of latent Mycobacterium tuberculosis. Active tuberculosis characterized by clinical manifestation and active symptoms compatible with tuberc...
Comprehensive, easy-to-understand information about this condition
How we create this content →The limited documentation surrounding active tuberculosis is primarily due to its complex nature and the fact that it affects millions globally. However, systematic studies have been challenging due to the variability in clinical presentation and the emergence of drug-resistant strains. Additionally, the lack of identified genetic factors contributes to the difficulty in establishing a comprehensive clinical profile.
To navigate your care for active tuberculosis, consider seeking a specialist in infectious diseases, particularly one with experience in tuberculosis management. Resources such as the CDC's TB website (cdc.gov/tb) provide valuable information. Additionally, inquire about participating in clinical trials, as these may offer access to cutting-edge treatments. While there are no specific patient organizations listed, connecting with local health departments may provide support and resources.
There are several orphan drugs designated for the treatment of active tuberculosis, including bedaquiline, telacebec, and tubimod, among others. Currently, there are 281 active clinical trials exploring various treatment options and approaches for managing active TB. You can find more information about these trials at ClinicalTrials.gov by searching for 'active tuberculosis'. This ongoing research offers hope for improved treatment strategies.
Actionable guidance for navigating care for active tuberculosis
To navigate your care for active tuberculosis, consider seeking a specialist in infectious diseases, particularly one with experience in tuberculosis management. Resources such as the CDC's TB website (cdc.gov/tb) provide valuable information. Additionally, inquire about participating in clinical trials, as these may offer access to cutting-edge treatments. While there are no specific patient organizations listed, connecting with local health departments may provide support and resources.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding active tuberculosis is primarily due to its complex nature and the fact that it affects millions globally. However, systematic studies have been challenging due to the variability in clinical presentation and the emergence of drug-resistant strains. Additionally, the lack of identified genetic factors contributes to the difficulty in establishing a comprehensive clinical profile.
To navigate your care for active tuberculosis, consider seeking a specialist in infectious diseases, particularly one with experience in tuberculosis management. Resources such as the CDC's TB website (cdc.gov/tb) provide valuable information. Additionally, inquire about participating in clinical trials, as these may offer access to cutting-edge treatments. While there are no specific patient organizations listed, connecting with local health departments may provide support and resources.
There are several orphan drugs designated for the treatment of active tuberculosis, including bedaquiline, telacebec, and tubimod, among others. Currently, there are 281 active clinical trials exploring various treatment options and approaches for managing active TB. You can find more information about these trials at ClinicalTrials.gov by searching for 'active tuberculosis'. This ongoing research offers hope for improved treatment strategies.
Actionable guidance for navigating care for active tuberculosis
To navigate your care for active tuberculosis, consider seeking a specialist in infectious diseases, particularly one with experience in tuberculosis management. Resources such as the CDC's TB website (cdc.gov/tb) provide valuable information. Additionally, inquire about participating in clinical trials, as these may offer access to cutting-edge treatments. While there are no specific patient organizations listed, connecting with local health departments may provide support and resources.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding active tuberculosis is primarily due to its complex nature and the fact that it affects millions globally. However, systematic studies have been challenging due to the variability in clinical presentation and the emergence of drug-resistant strains. Additionally, the lack of identified genetic factors contributes to the difficulty in establishing a comprehensive clinical profile.
To navigate your care for active tuberculosis, consider seeking a specialist in infectious diseases, particularly one with experience in tuberculosis management. Resources such as the CDC's TB website (cdc.gov/tb) provide valuable information. Additionally, inquire about participating in clinical trials, as these may offer access to cutting-edge treatments. While there are no specific patient organizations listed, connecting with local health departments may provide support and resources.
There are several orphan drugs designated for the treatment of active tuberculosis, including bedaquiline, telacebec, and tubimod, among others. Currently, there are 281 active clinical trials exploring various treatment options and approaches for managing active TB. You can find more information about these trials at ClinicalTrials.gov by searching for 'active tuberculosis'. This ongoing research offers hope for improved treatment strategies.
Actionable guidance for navigating care for active tuberculosis
To navigate your care for active tuberculosis, consider seeking a specialist in infectious diseases, particularly one with experience in tuberculosis management. Resources such as the CDC's TB website (cdc.gov/tb) provide valuable information. Additionally, inquire about participating in clinical trials, as these may offer access to cutting-edge treatments. While there are no specific patient organizations listed, connecting with local health departments may provide support and resources.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 6 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.